Removing Gaps in Data Integrity

Between January 2015 and May 2016 there was a total of 28 warning letters issued to pharmaceutical manufacturers. 21 of those letters were centered around issues involving data integrity.  If data is mutilated and changed, it does not promise that a product is safe, data integrity is extremely important to follow.  It is used to … Read more

Manual Visual Inspection is Still Critical

Automated visual inspection has been created to perform as an alternative to manual visual inspection.  This type of inspection is used to lower the cost and speed up the inspection process; pushing more drugs into the market.  In USP <1790> it explains that any inspection other than manual inspection has to be “equivalent or better … Read more

Testing Container Closures with Dye Ingress Method

The dye ingress test method is a routine test for container closures attached to parenteral drugs and large molecule drugs.  Traditionally, this method uses ten test samples and three positive controls.  During this testing, the test samples are place in a vacuum chamber and pressurized with dye.  Three vials are punctured to allow dye to … Read more

Testing Container Closures

During the manufacturing process of injectable drugs, all pieces and parts need to go through a visual inspection process.  The container, closure, product and final product all need to have individual inspections.  Container closure integrity is extremely important, especially when involved with parenteral drugs.  Parenteral drugs have the highest risk packaging application concern for closure … Read more